Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy
Francesca Menniti‐Ippolito(National Institute of Health), Mario Cioffi, Francesca Colavita(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Vincenzo Panuccio, Flavia Chiarotti, N. Paudice, Giuseppe Di Natale, Nicola Spetrino, Concetta Castilletti(Czech Academy of Sciences), Giovanna Parlongo, Francesca Mallamaci(Società Italiana di Nefrologia), Lorenzo Di Liberato, Alfonso De Maio(Azienda Ospedaliero-Universitaria Careggi), Francesca Bianchini(University of Florence), F. Leone, Giovanni Baglìo, Mario Salomone(Ospedale Maggiore di Chieri), Domenico Tramontana, Pasqualina Acconcia, Marilina Siani(Ospedale Maggiore di Chieri), Carlo Sapio, Rosita Greco(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Andrea Lorimer, Carmine Zoccali(Biogem), Massimo Fabiani, Irma Figlia, Luigi Amoroso, Piergiorgio Messa(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Martina Ceseri, Salvatore Cascone, Aldo P. Maggioni(Health Care Foundation), Teresa Papalia, Ester Baldini(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Roberto Pititto, Ivania Maria Figliano, Salvatore De Masi(Azienda Ospedaliero-Universitaria Careggi), Alfonso Mele, Giuseppe Traversa, Roberto Da, Andrea Mariano, Francesco D’Agostino, M. Campolo, Domenico Caserta, Maria Rosa La Gamba(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Laura Sarti, Anna Maria Frangiosa, Eva Alessi(Italian Medicines Agency), Milva Di Giovanni, Santo Vitiello
Cited by 4
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
|New England Journal of Medicine|2003|2.5k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k